Navigation Links
Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Date:5/25/2011

Cancer Research UK, one of the largest independent funders of cancer research in the world.  CRT's discovery laboratories build on exploratory research to create attractive commercial opportunities through collaboration with research institutes worldwide. Therapeutic programmes are then out-licensed for further development following identification of a suitable partner.

For more information visit www.cancertechnology.co.uk

About Cancer Research UK's Drug Development OfficeCancer Research UK has an impressive record of developing novel treatments for cancer. It currently has a portfolio of around 36 new anti-cancer agents in preclinical development, phase I or early phase II clinical trials. Since 1982, the Cancer Research UK Drug Development Office has taken over 100 potential new anti-cancer agents into clinical trials in patients, five of which have made it to market and many others are still in clinical development. These include Temozolomide, a drug discovered by Cancer Research UK scientists, that is an effective new treatment for brain cancer. Six other drugs are in late development phase III trials. This rate of success is comparable to that of any pharmaceutical company.

About Centella TherapeuticsCentella Therapeutics, Inc. is a wholly owned subsidiary of Varian Medical Systems, Inc. (NYSE: VAR). Varian, headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy. Centella, which was previously known as Centella biotechnologies, inc., is a dedicated enterprise focused on discovery and development of cancer treatments at the intersection of radiotherapy and pharmaceutical therapeutics.   Centella's mission is to develop a portfolio of drugs with a focus on enhancing the effectiveness of radiotherapy, making Centella the first Radiation Oncology Bi
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ... "Laboratory Centrifuges - Global Strategic Business Report" ... and forecasts are provided for the period 2014 ... provided for these markets. Market data and analytics ... profiles are primarily based on public domain information ...
(Date:6/2/2015)... N.C. , June 2, 2015 BioDelivery Sciences ... weather conditions, the presentation by Dr. Mark A. Sirgo ... changed to 2:30 PM Eastern time. Jefferies 2015 ... Grand Hyatt, New York City , ... can be accessed at www.bdsi.com .  For those who ...
(Date:6/2/2015)...  One hundred percent of Adventist University of Health ... graduates of April 2015 have passed the national certification ... was composed of 20 students who completed the program ... is required of every graduate in order to become ... MSNA program are eligible for state licensure as Advanced ...
Breaking Medicine Technology:Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2
... , , JERUSALEM ... announced today that the Data Monitoring Committee (DMC) has,independently reviewed preliminary ... ExCell) and has recommended that the JV,continue to enroll patients in ... Q2 2010. StemEx is being evaluated as a,therapeutic treatment for adolescents ...
... , , , ... , - StemEx Study is Enrolling Patients ... Hungary and Israel . , Elbit ... 28% holding on a fully diluted basis),Gamida Cell Ltd. ("Gamida Cell") through the ...
Cached Medicine Technology:Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 4Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 5
(Date:6/2/2015)... OR (PRWEB) June 02, 2015 ZOOM+, ... of ZOOM+ Performance Health Insurance, announced today the opening ... Clean White 57 - a three-in-one complete dental exam, ... Clean Jr. for kids. Like all ZOOM+ services, ZOOM+Smile ... , “Why shouldn’t the dentist office be as inviting ...
(Date:6/2/2015)... 2015 With a dedicated focus to become ... Care has hired Leslie Young as director of human ... initiatives to better understand and respond to the distinct needs ... communities in 13 states across the country. , “As we ... support to our residents, we are making it an equal ...
(Date:6/2/2015)... Alberta (PRWEB) June 02, 2015 ... wireless technology, highlights North Pole Engineering’s (NPE) announcement ... ANT Wireless technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. WASP ... ANT-FS) and Bluetooth Smart® bridge solution that allows ... transmitted over WiFi or Ethernet networks. ...
(Date:6/2/2015)... PA (PRWEB) June 02, 2015 For ... may be too exposed to harmful germs, chemicals and ... warranted. However, thanks to an inventor from Queens Village, ... SQUEEZE to provide an efficient, fun, hygienic way to ... of being exposed to bugs, chemicals and germs. Furthermore, ...
(Date:6/2/2015)... Vancouver, BC – According to ... http://www.idataresearch.com ), the bone graft substitute market is ... over traditional allograft materials. Because the use of ... increase in operation time, alternative graft options are ... these synthetic materials is partly the result of ...
Breaking Medicine News(10 mins):Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3
... Reporter , FRIDAY, Sept. 23 (HealthDay News) -- Fred Wyand ... of the public health response to human papillomavirus, or HPV. ... HPV News , a bimonthly newsletter published by the American ... 1990s. HPV is a sexually transmitted disease that most ...
... -- The University of South Florida School of Physical ... Department of Defense award for leading-edge musculoskeletal research intended ... military preparedness. The award will fund two major ... regimen may protect against low back injury in combat ...
... (HealthDay News) -- There is a genetic link between ... brain disorders, a new study indicates. Researchers identified ... discovered before, which play a role in people,s risk ... new insight into the causes of both conditions. ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, ... arrow through the credibility of claims that a virus ... results from nine different labs around the United States ... solely on the basis of whether they tested positive ...
... The human brain doesn,t stop developing at adolescence, but continues ... of Medicine & Dentistry at the University of Alberta. ... that the human brain stopped developing in adolescence. But now ... case, thanks to medical research conducted in the Department of ...
... (SALT LAKE CITY)University of Utah biochemist Brenda L. Bass, ... less traveled. That bent hasn,t come ... distinguished professor of biochemistry who researches double-stranded RNA (dsRNA), ... fully understood. But Bass has made substantial discoveries involving ...
Cached Medicine News:Health News:Stress the 'Human' in HPV, One Man Suggests 2Health News:Stress the 'Human' in HPV, One Man Suggests 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 2Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 4Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 5Health News:Genetic Links Seen Between Bipolar Illness and Schizophrenia 2Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 2Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 3Health News:Some brain wiring continues to develop well into our 20s: U of A study 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 3Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 4
... The AVX catheter is designed ... to 12mm. High-pressure saline jets travel ... sound to create a low pressure ... is drawn into the catheter where ...
... Rheolytic Thrombectomy catheter is designed to offer ... jets create a low pressure zone around ... Thrombus is drawn into the catheter, where ... removed from the body.,AngioJet thrombectomy provides rapid ...
... System combines the legendary accuracy of the ... Windows* software. It integrates seamlessly into ... that enhance your clinical capabilities in an ... future of EP. The intended use ...
... are meeting the clinical needs of ... anesthesiologists. And, they are of the ... Medtronic.,Effective pacing with the adjustment of ... quick battery changes. Both the ...
Medicine Products: